miRagen Therapeutics Inc (MGEN.OQ)
MGEN.OQ on NASDAQ Stock Exchange Capital Market
2.96USD
14 Dec 2018
2.96USD
14 Dec 2018
Change (% chg)
$-0.04 (-1.33%)
$-0.04 (-1.33%)
Prev Close
$3.00
$3.00
Open
$2.99
$2.99
Day's High
$3.22
$3.22
Day's Low
$2.93
$2.93
Volume
122,163
122,163
Avg. Vol
32,285
32,285
52-wk High
$10.68
$10.68
52-wk Low
$2.72
$2.72
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
| Name | Age | Since | Current Position |
|---|---|---|---|
Jeffrey Hatfield |
2018 | Chairman of the Board | |
William Marshall |
53 | 2017 | President, Chief Executive Officer, Director |
Jason Leverone |
43 | 2017 | Chief Financial Officer, Treasurer, Secretary |
Paul Rubin |
63 | 2017 | Executive Vice President - Research and Development |
Adam Levy |
38 | 2017 | Chief Business Officer |